SCHEMBL24252672

SCHEMBL24252672

Nc1cnnc2cc(-c3cc(B(O)O)ccc3N3CCCC3)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.36
NR1I2 O75469 2/20 0.34
SMARCA2 P51531 2/20 0.34
SMARCA4 P51532 2/20 0.34
PBRM1 Q86U86 2/20 0.34
S100B P04271 1/20 0.32
KDM4E B2RXH2 3/20 0.32
GAA P10253 3/20 0.32
PIK3CD O00329 2/20 0.32
PIK3CA P42336 2/20 0.32
PIK3CB P42338 2/20 0.32
PIK3CG P48736 2/20 0.32
HSD17B10 Q99714 1/20 0.32
POLB P06746 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NCF1 P14598 1/20 0.31
ALDH1A1 P00352 2/20 0.31
HTT P42858 2/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL30467631 0.95 FEN1 (0.33) FEN1NR1I2SMARCA2SMARCA4PBRM1
Formic Acid SCHEMBL25250167 0.95 FEN1 (0.33) FEN1NR1I2SMARCA2SMARCA4PBRM1
SCHEMBL24252619 0.92 PDE10A (0.40) KDM4EGAAPIK3CDPIK3CAPIK3CB
SCHEMBL26771374 0.91 FEN1 (0.35) FEN1NR1I2SMARCA2SMARCA4PBRM1
Formic Acid SCHEMBL25240502 0.87 LRRK2 (0.39) KDM4EGAAPIK3CDPIK3CAPIK3CB
Formic Acid SCHEMBL30467686 0.87 LRRK2 (0.39) KDM4EGAAPIK3CDPIK3CAPIK3CB
SCHEMBL25250165 0.86 FEN1 (0.32) FEN1PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL25840702 0.85 PLG (0.34) PDE10A
SCHEMBL26771355 0.83 PDE10A (0.41) GAAPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30462795 0.83 PLG (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 FEN1 2638/4885NR1I2 1679/4885SMARCA2 4570/4885
US-11814404-B2 Inhibitors of complement factors and uses thereof CFB, CFH, C9 FEN1 2638/4885NR1I2 1679/4885SMARCA2 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.